- Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepboundon April 4, 2025 at 9:34 pm
The Biden administration proposal would have significantly expanded access to obesity to millions of Americans but would have cost the government billions.
- Medicare, Medicaid agency cuts jobs from minority health office, other divisions, as RFK Jr. guts U.S. health departmenton April 4, 2025 at 8:10 pm
CMS detailed some of the specific offices impacted by cuts under Kennedy's broader plan to restructure the Department of Health and Human Services.
- We're exiting our position in a health-care stock to raise some cashon April 4, 2025 at 12:33 pm
We're cutting loose the smallest position in our portfolio.
- Europe's pharma industry braces for tariffs as carve-out hopes fadeon April 2, 2025 at 4:04 pm
Europe's pharmaceutical sector is bracing for the potential impact of U.S. tariffs as hopes of an industry-wide exemption by President Donald Trump fade.
- Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaroon April 2, 2025 at 12:50 am
Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.
- Hims & Hers shares rise as company adds new weight-loss medications to platformon April 1, 2025 at 11:32 pm
Hims & Hers is adding Zepbound, Mounjaro, and the generic injection liraglutide to its platform.
- Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats upon April 1, 2025 at 5:47 pm
AstraZeneca's new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.
Click Advertiser ♥
-
-
-
-